ID

31668

Beskrivning

A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT02225262

Länk

https://clinicaltrials.gov/show/NCT02225262

Nyckelord

Versioner (2)
  1. 2018-09-18 2018-09-18 -
  2. 2018-09-18 2018-09-18 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

18 september 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT02225262

Engelsk

Eligibility Prostate Cancer NCT02225262

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
male age ≥ 21
Beskrivning

Gender | Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
histologically proven prostate adenocarcinoma
Beskrivning

Adenocarcinoma of prostate

Datatyp

boolean

Alias
UMLS CUI [1]
C0007112
clinical stage t1b-t2b, n0-nx, m0-mx (ajcc 6th edition)
Beskrivning

TNM clinical staging

Datatyp

boolean

Alias
UMLS CUI [1]
C3258246
psa ≤ 20 ng/ml
Beskrivning

Prostate specific antigen measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0201544
prostate volume ≤ 100 cc
Beskrivning

Prostate volume

Datatyp

boolean

Alias
UMLS CUI [1]
C1441416
patients belonging in one of the following risk groups:
Beskrivning

Risk Groups

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0035647
UMLS CUI [1,2]
C0441833
low:
Beskrivning

Low Risk

Datatyp

boolean

Alias
UMLS CUI [1]
C3538919
cs t1b-t2a and gleason 2-6 and psa ≤ 10
Beskrivning

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
intermediate:
Beskrivning

Intermediate Risk

Datatyp

boolean

Alias
UMLS CUI [1]
C3640764
cs t2b and gleason 2-6 and psa ≤ 10, or
Beskrivning

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
cs t1b-t2b, and gleason 2-6 and psa ≤ 20 ng/ml or gleason 7 and psa ≤ 10 ng/ml
Beskrivning

TNM clinical staging | Gleason score | Prostate specific antigen measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
any histology other than adenocarcinoma
Beskrivning

Histology Any | Exception Adenocarcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0344441
UMLS CUI [1,2]
C1552551
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0001418
age < 21
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
kps <= 40 <70
Beskrivning

Karnofsky Performance Status

Datatyp

boolean

Alias
UMLS CUI [1]
C0206065
ecog performance status ≥ 2
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
patient weight >350 lbs. (table limitation)
Beskrivning

Body Weight

Datatyp

boolean

Alias
UMLS CUI [1]
C0005910
prior xrt to prostate or lower pelvis
Beskrivning

Prostate external beam radiation therapy | External Radiation Therapy Pelvis Lower

Datatyp

boolean

Alias
UMLS CUI [1]
C0860348
UMLS CUI [2,1]
C1517033
UMLS CUI [2,2]
C0030797
UMLS CUI [2,3]
C0441994
prior surgery or cryotherapy to prostate
Beskrivning

Operation on prostate | Cryotherapy of prostate

Datatyp

boolean

Alias
UMLS CUI [1]
C0194790
UMLS CUI [2]
C3544233
implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
Beskrivning

Materials Implanted Preventing Treatment Plan | Materials Implanted Preventing Therapeutic procedure

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0520510
UMLS CUI [1,2]
C0021102
UMLS CUI [1,3]
C1292733
UMLS CUI [1,4]
C0599880
UMLS CUI [2,1]
C0520510
UMLS CUI [2,2]
C0021102
UMLS CUI [2,3]
C1292733
UMLS CUI [2,4]
C0087111
chemotherapy for a malignancy in the last 5 years
Beskrivning

Chemotherapy Malignant Neoplasms

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0006826
history of an invasive malignancy (other than this prostate cancer, or basal or squamous skin cancers) in the last 5 years
Beskrivning

Invasive cancer | Exception Prostate carcinoma | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin

Datatyp

boolean

Alias
UMLS CUI [1]
C0677898
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0600139
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007117
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0553723
hormone ablation for 2 months prior to enrollment, or during treatment
Beskrivning

Antiandrogen therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0279492
Tillbaka till toppen

Similar models

Eligibility Prostate Cancer NCT02225262

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
male age ≥ 21
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Adenocarcinoma of prostate
Item
histologically proven prostate adenocarcinoma
boolean
C0007112 (UMLS CUI [1])
TNM clinical staging
Item
clinical stage t1b-t2b, n0-nx, m0-mx (ajcc 6th edition)
boolean
C3258246 (UMLS CUI [1])
Prostate specific antigen measurement
Item
psa ≤ 20 ng/ml
boolean
C0201544 (UMLS CUI [1])
Prostate volume
Item
prostate volume ≤ 100 cc
boolean
C1441416 (UMLS CUI [1])
Risk Groups
Item
patients belonging in one of the following risk groups:
boolean
C0035647 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
Low Risk
Item
low:
boolean
C3538919 (UMLS CUI [1])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
cs t1b-t2a and gleason 2-6 and psa ≤ 10
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
Intermediate Risk
Item
intermediate:
boolean
C3640764 (UMLS CUI [1])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
cs t2b and gleason 2-6 and psa ≤ 10, or
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
cs t1b-t2b, and gleason 2-6 and psa ≤ 20 ng/ml or gleason 7 and psa ≤ 10 ng/ml
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Histology Any | Exception Adenocarcinoma
Item
any histology other than adenocarcinoma
boolean
C0344441 (UMLS CUI [1,1])
C1552551 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0001418 (UMLS CUI [2,2])
Age
Item
age < 21
boolean
C0001779 (UMLS CUI [1])
Karnofsky Performance Status
Item
kps <= 40 <70
boolean
C0206065 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status ≥ 2
boolean
C1520224 (UMLS CUI [1])
Body Weight
Item
patient weight >350 lbs. (table limitation)
boolean
C0005910 (UMLS CUI [1])
Prostate external beam radiation therapy | External Radiation Therapy Pelvis Lower
Item
prior xrt to prostate or lower pelvis
boolean
C0860348 (UMLS CUI [1])
C1517033 (UMLS CUI [2,1])
C0030797 (UMLS CUI [2,2])
C0441994 (UMLS CUI [2,3])
Operation on prostate | Cryotherapy of prostate
Item
prior surgery or cryotherapy to prostate
boolean
C0194790 (UMLS CUI [1])
C3544233 (UMLS CUI [2])
Materials Implanted Preventing Treatment Plan | Materials Implanted Preventing Therapeutic procedure
Item
implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
boolean
C0520510 (UMLS CUI [1,1])
C0021102 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C0599880 (UMLS CUI [1,4])
C0520510 (UMLS CUI [2,1])
C0021102 (UMLS CUI [2,2])
C1292733 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
Chemotherapy Malignant Neoplasms
Item
chemotherapy for a malignancy in the last 5 years
boolean
C0392920 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Invasive cancer | Exception Prostate carcinoma | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
history of an invasive malignancy (other than this prostate cancer, or basal or squamous skin cancers) in the last 5 years
boolean
C0677898 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
Antiandrogen therapy
Item
hormone ablation for 2 months prior to enrollment, or during treatment
boolean
C0279492 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial